Phosphagenics Limited - Product Pipeline Review - 2014

Date: December 10, 2014
Pages: 38
Price:
US$ 1,500.00 US$ 1,200.00
Offer valid until December 31, 2016!
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: P006E6BB3A4EN
Leaflet:

Download PDF Leaflet

Phosphagenics Limited - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Phosphagenics Limited - Product Pipeline Review - 2014’, provides an overview of the Phosphagenics Limited’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Phosphagenics Limited’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
  • The report provides brief overview of Phosphagenics Limited including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Phosphagenics Limited’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Phosphagenics Limited’s pipeline products
Reasons to buy
  • Evaluate Phosphagenics Limited’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Phosphagenics Limited in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Phosphagenics Limited’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Phosphagenics Limited and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Phosphagenics Limited
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Phosphagenics Limited and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues
Phosphagenics Limited Snapshot
Phosphagenics Limited Overview
Key Information
Key Facts
Phosphagenics Limited - Research and Development Overview
Key Therapeutic Areas
Phosphagenics Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Phosphagenics Limited - Pipeline Products Glance
Phosphagenics Limited - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Phosphagenics Limited - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Phosphagenics Limited - Drug Profiles
tretinoin
Product Description
Mechanism of Action
R&D Progress
ketoconazole
Product Description
Mechanism of Action
R&D Progress
lidocaine
Product Description
Mechanism of Action
R&D Progress
oxycodone ER
Product Description
Mechanism of Action
R&D Progress
oxymorphone hydrochloride
Product Description
Mechanism of Action
R&D Progress
diclofenac sodium
Product Description
Mechanism of Action
R&D Progress
Drug for Acne
Product Description
Mechanism of Action
R&D Progress
propofol
Product Description
Mechanism of Action
R&D Progress
Proteins for Undisclosed Indication
Product Description
Mechanism of Action
R&D Progress
Phosphagenics Limited - Pipeline Analysis
Phosphagenics Limited - Pipeline Products by Target
Phosphagenics Limited - Pipeline Products by Route of Administration
Phosphagenics Limited - Pipeline Products by Molecule Type
Phosphagenics Limited - Pipeline Products by Mechanism of Action
Phosphagenics Limited - Recent Pipeline Updates
Phosphagenics Limited - Dormant Projects
Phosphagenics Limited - Company Statement
Phosphagenics Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Phosphagenics Limited, Key Information
Phosphagenics Limited, Key Facts
Phosphagenics Limited - Pipeline by Indication, 2014
Phosphagenics Limited - Pipeline by Stage of Development, 2014
Phosphagenics Limited - Monotherapy Products in Pipeline, 2014
Phosphagenics Limited - Phase II, 2014
Phosphagenics Limited - Phase I, 2014
Phosphagenics Limited - Preclinical, 2014
Phosphagenics Limited - Discovery, 2014
Phosphagenics Limited - Pipeline by Target, 2014
Phosphagenics Limited - Pipeline by Route of Administration, 2014
Phosphagenics Limited - Pipeline by Molecule Type, 2014
Phosphagenics Limited - Pipeline Products by Mechanism of Action, 2014
Phosphagenics Limited - Recent Pipeline Updates, 2014
Phosphagenics Limited - Dormant Developmental Projects,2014
Phosphagenics Limited, Other Locations
Phosphagenics Limited, Subsidiaries

LIST OF FIGURES

Phosphagenics Limited - Pipeline by Top 10 Indication, 2014
Phosphagenics Limited - Pipeline by Stage of Development, 2014
Phosphagenics Limited - Monotherapy Products in Pipeline, 2014
Phosphagenics Limited - Pipeline by Top 10 Target, 2014
Phosphagenics Limited - Pipeline by Top 10 Route of Administration, 2014
Phosphagenics Limited - Pipeline by Top 10 Molecule Type, 2014
Phosphagenics Limited - Pipeline Products by Top 10 Mechanism of Action, 2014
Skip to top


Mesoblast Limited - Product Pipeline Review - 2015 US$ 1,200.00 Oct, 2015 · 51 pages
Pharminox Limited - Product Pipeline Review - 2015 US$ 1,200.00 Jul, 2015 · 21 pages
Cellmid Limited - Product Pipeline Review - 2015 US$ 1,200.00 Oct, 2015 · 30 pages
Immunocore Limited - Product Pipeline Review - 2015 US$ 1,200.00 May, 2015 · 33 pages

Ask Your Question

Phosphagenics Limited - Product Pipeline Review - 2014
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: